Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Treasury Shares (2021 - 2025)

Alx Oncology Holdings' Treasury Shares history spans 3 years, with the latest figure at $949669.0 for Q4 2023.

  • On a quarterly basis, Treasury Shares rose 15.77% to $949669.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $949669.0, a 15.77% increase, with the full-year FY2023 number at $949669.0, up 15.77% from a year prior.
  • Treasury Shares hit $949669.0 in Q4 2023 for Alx Oncology Holdings, up from $820326.0 in the prior quarter.
  • Over the last five years, Treasury Shares for ALXO hit a ceiling of $949669.0 in Q4 2023 and a floor of $15075.0 in Q4 2021.
  • Historically, Treasury Shares has averaged $608236.3 across 3 years, with a median of $660356.5 in 2022.
  • Biggest five-year swings in Treasury Shares: surged 5341.63% in 2022 and later increased 15.77% in 2023.
  • Tracing ALXO's Treasury Shares over 3 years: stood at $15075.0 in 2021, then surged by 5341.63% to $820326.0 in 2022, then increased by 15.77% to $949669.0 in 2023.
  • Business Quant data shows Treasury Shares for ALXO at $949669.0 in Q4 2023, $820326.0 in Q4 2022, and $870399.0 in Q3 2022.